{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:25:03Z","timestamp":1792074303749,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T00:00:00Z","timestamp":1255046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/bf03346550","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T21:47:23Z","timestamp":1396043243000},"page":"54-60","source":"Crossref","is-referenced-by-count":15,"title":["Endocrine tumors: The evolving role of positron emission tomography in diagnosis and management"],"prefix":"10.1007","volume":"33","author":[{"given":"M.","family":"Naji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hodolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"El-Refai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Marzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Al-Nahhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,9]]},"reference":[{"key":"BF03346550_CR1","first-page":"41","volume":"33","author":"S Khan","year":"2008","unstructured":"Khan S, Lloyd C, Szyszko T, Win Z, Rubello D, Al-Nahhas A. PET imaging in endocrine tumours. Minerva Endocrinol 2008, 33: 41\u201352.","journal-title":"Minerva Endocrinol"},{"key":"BF03346550_CR2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1530\/eje.1.01839","volume":"152","author":"A Markou","year":"2005","unstructured":"Markou A, Manning P, Kaya B, Datta SN, Bomanji JB, Conway GS. 18F fluoro-2-deoxy-D-glucose (18F FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing\u2019s syndrome. Eur J Endocrinol 2005, 152: 521\u20135.","journal-title":"Eur J Endocrinol"},{"key":"BF03346550_CR3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/er.2003-0032","volume":"25","author":"K Pacak","year":"2004","unstructured":"Pacak K, Eisenhofer G, Goldstein DS. Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 2004, 25: 568\u201380.","journal-title":"Endocr Rev"},{"key":"BF03346550_CR4","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1148\/rg.266065057","volume":"26","author":"S Chong","year":"2006","unstructured":"Chong S, Lee KS, Kim HY, et al. Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. Radiographics 2006, 26: 1811\u201326.","journal-title":"Radiographics"},{"key":"BF03346550_CR5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jc.2005-1540","volume":"91","author":"S Leboulleux","year":"2006","unstructured":"Leboulleux S, Dromain C, Bonniaud G, et al. Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab 2006, 91: 920\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346550_CR6","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1148\/radiol.2383042164","volume":"238","author":"MA Blake","year":"2006","unstructured":"Blake MA, Slattery JM, Kalra MK, et al. Adrenal lesions: characterization with fused PET\/CT image in patients with proved or suspected malignancy initial experience. Radiology 2006, 238: 970\u20137.","journal-title":"Radiology"},{"key":"BF03346550_CR7","first-page":"275","volume":"41","author":"M Bergstr\u00f6m","year":"2000","unstructured":"Bergstr\u00f6m M, Juhlin C, Bonasera T A, Sundin A, Rastad J, Akerstrom G, L\u00e5ngstr\u00f6m B. PET Imaging of adrenal cortical tumors with the 11B-hydroxylasetracer 11C-metomidate. J Nucl Med 2000, 41: 275\u201382; Comment in J Nucl Med 2000, 41: 1933\u20134.","journal-title":"J Nucl Med"},{"key":"BF03346550_CR8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cpet.2008.04.002","volume":"2","author":"R Kumar","year":"2007","unstructured":"Kumar R, Abass A, Fanti S. Adrenocortical positron emission tomography\/PET-CT imaging. PET Clinics 2007, 2: 331\u20139.","journal-title":"PET Clinics"},{"key":"BF03346550_CR9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00259-005-0062-6","volume":"33","author":"W Wadsak","year":"2006","unstructured":"Wadsak W, Mitterhauser M, Rendl G, et al. 18F FETO for adrenocortical PET imaging: a pilot study in healthy volunteers. Eur J Nucl Med Mol Imaging 2006, 33: 669\u201372.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BF03346550_CR10","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1148\/rg.24si045506","volume":"24","author":"M Blake","year":"2004","unstructured":"Blake M, Kalra M, Maher M, et al. Pheochromocytoma: an imaging chameleon. Radiographics 2004, 24: S87\u201399.","journal-title":"Radiographics"},{"key":"BF03346550_CR11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/01.HYP.0000125014.56023.b8","volume":"43","author":"DS Goldstein","year":"2004","unstructured":"Goldstein DS, Eisenhofer G, Flynn JA, Wand G, Pacak K. Diagnosis and localization of phaeochromocytoma. Hypertension 2004, 43: 907\u201310.","journal-title":"Hypertension"},{"key":"BF03346550_CR12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.beem.2004.10.001","volume":"19","author":"SA Sohaib","year":"2005","unstructured":"Sohaib SA, Rockall AG, Reznek RH. Imaging functional adrenal disorders. Best Pract Res Clin Endocrinol Metab 2005, 19: 293\u2013310.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"BF03346550_CR13","first-page":"150","volume":"48","author":"E Bombardieri","year":"2004","unstructured":"Bombardieri E, Seregni E, Villano C, Chiti A, Bajetta E. Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors. Q J Nucl Med Mol Imaging 2004, 48: 150\u201363.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"BF03346550_CR14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1677\/ERC-07-0074","volume":"14","author":"A Chrisoulidou","year":"2007","unstructured":"Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB. The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer 2007, 14: 569\u201385.","journal-title":"Endocr Relat Cancer"},{"key":"BF03346550_CR15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1677\/ERC-07-0045","volume":"14","author":"I Ilias","year":"2007","unstructured":"Ilias I, Sahdev A, Reznek RH, Grossman AB, Pacak K. The optimal imaging of adrenal tumours: a comparison of different methods. Endoc Relat Cancer 2007, 14: 587\u201399.","journal-title":"Endoc Relat Cancer"},{"key":"BF03346550_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11102-006-0269-y","volume":"9","author":"FM Mottaghy","year":"2006","unstructured":"Mottaghy FM, Reske SN. Functional imaging of neuroendocrine tumours with PET. Pituitary 2006, 9: 237\u201342.","journal-title":"Pituitary"},{"key":"BF03346550_CR17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1148\/radiol.2302021678","volume":"230","author":"C Trampal","year":"2004","unstructured":"Trampal C, Engler H, Juhlin C, Bergstrom M, Langstrom B. Pheochromocytomas: Detection with 11C Hydroxyephedrine PET. Radiology 2004, 230: 423\u20138.","journal-title":"Radiology"},{"key":"BF03346550_CR18","first-page":"1125","volume":"33","author":"BL Shulkin","year":"1992","unstructured":"Shulkin BL, Wieland DM, Schwaiger M, et al. PET scanning with hydroxyephedrine: an approach to the location of phaeochromocytoma. J Nucl Med 1992, 33: 1125\u201331.","journal-title":"J Nucl Med"},{"key":"BF03346550_CR19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cpet.2008.04.007","volume":"2","author":"V Prasad","year":"2007","unstructured":"Prasad V, Ambrosini V, Alavi A, Fanti S, Baum R. PET\/CT in neuroendocrine tumors: evaluation of receptor status and metabolism. PET Clinics 2007, 2: 351\u201375.","journal-title":"PET Clinics"},{"key":"BF03346550_CR20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1210\/jc.2002-021354","volume":"88","author":"L Gourgiotis","year":"2003","unstructured":"Gourgiotis L, Sarlis NJ, Reynolds JC, Vanwaes C, Merino MJ, Pacak K. Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]-fluorodopamine positron emission tomography. J Clin Endocrinol Metab 2003, 88: 637\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346550_CR21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cpet.2008.04.003","volume":"2","author":"S Khan","year":"2007","unstructured":"Khan S, Win Z, Szyszko T, et al. PET imaging of phaeochromocytoma. PET Clinics 2007, 2: 341\u20139.","journal-title":"PET Clinics"},{"key":"BF03346550_CR22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/EJE-06-0712","volume":"156","author":"P Kaji","year":"2007","unstructured":"Kaji P, Carrasquillo JA, Linehan WM, et al. The role of 6-[18F]-fluorodopamine positron emission tomography in the localization of adrenal phaeochromocytoma associated with von Hippel-Lindau syndrome. Eur J Endocrinol 2007, 156: 483\u20137.","journal-title":"Eur J Endocrinol"},{"key":"BF03346550_CR23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2222010622","volume":"222","author":"S Hoegerle","year":"2002","unstructured":"Hoegerle S, Nitzsche E, Altehoefer C, et al. Phaeochromocytomas: detection with 18F DOPA whole body PET-initial results. Radiology 2002, 222: 507\u201312.","journal-title":"Radiology"},{"key":"BF03346550_CR24","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1210\/jc.2003-030235","volume":"88","author":"I Ilias","year":"2003","unstructured":"Ilias I, Yu J, Carrasquillo JA, Chen C, et al. Superiority of 6-[18F] fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Endocrinol Metab 2003, 88: 4083\u20137.","journal-title":"J Endocrinol Metab"},{"key":"BF03346550_CR25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1148\/rg.275065729","volume":"27","author":"C Intenzo","year":"2007","unstructured":"Intenzo C, Jabbour S, Lin H, et al. Scintigraphic imaging of body neuroendocrine tumors. Radiographies 2007, 27: 1355\u201369.","journal-title":"Radiographies"},{"key":"BF03346550_CR26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MNM.0b013e3282ffd70d","volume":"29","author":"V Ambrosini","year":"2008","unstructured":"Ambrosini V, Rubello D, Nanni C, Al Nahhas A, Fanti S. 68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients. Nucl Med Commun 2008, 29: 415\u20137.","journal-title":"Nucl Med Commun"},{"key":"BF03346550_CR27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.mnm.0000224462.44051.d2","volume":"27","author":"C Nanni","year":"2006","unstructured":"Nanni C, Rubello D, Al-Nahhas A, Fanti S. Clinical PET in oncology: not only FDG. Nucl Med Commun 2006, 27: 685\u20138.","journal-title":"Nucl Med Commun"},{"key":"BF03346550_CR28","first-page":"E21","volume":"51","author":"D Dalgorf","year":"2008","unstructured":"Dalgorf D, Higgins KM, Ehrlich L. PET\/CT fusion technology: its role in managing recurrent, well-differentiated thyroid cancer. Can J Surg 2008, 51: E21\u20132.","journal-title":"Can J Surg"},{"key":"BF03346550_CR29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s002590050493","volume":"26","author":"F Gr\u00fcnwald","year":"1999","unstructured":"Gr\u00fcnwald F, Kalicke T, Feine U, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography in thyroid cancer: result of a multicentre study. Eur J Nucl Med 1999, 26: 1547\u201352.","journal-title":"Eur J Nucl Med"},{"key":"BF03346550_CR30","first-page":"910","volume":"28","author":"H Joensuu","year":"1987","unstructured":"Joensuu H, Ahonen A. Imaging of Metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose. J Nucl Med 1987, 28: 910\u20134.","journal-title":"J Nucl Med"},{"key":"BF03346550_CR31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/105072502753522392","volume":"12","author":"M Plotkin","year":"2002","unstructured":"Plotkin M, Hautzel H, Krause BJ, et al. Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow up Hurthle cell thyroid cancer. Thyroid 2002, 12: 155\u201361.","journal-title":"Thyroid"},{"key":"BF03346550_CR32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1752-1947-1-133","volume":"1","author":"G Dionigi","year":"2007","unstructured":"Dionigi G, Castano P, Bertolini V, et al. Simultaneous medullary and papillary thyroid cancer: two case reports. J Med Case Reports 2007, 1: 133.","journal-title":"J Med Case Reports"},{"key":"BF03346550_CR33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cpet.2008.04.006","volume":"2","author":"M Urhan","year":"2007","unstructured":"Urhan M, Alavi A, Nanni C. The evolving role of positron emission tomography in patients with medullary thyroid carcinoma. PET Clinics 2007, 2: 305\u201311.","journal-title":"PET Clinics"},{"key":"BF03346550_CR34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2967\/jnumed.106.036681","volume":"48","author":"SC Ong","year":"2007","unstructured":"Ong SC, Sch\u00f6der H, Patel SG, et al. Diagnostic accuracy of 18FFDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med 2007, 48: 501\u20137.","journal-title":"J Nucl Med"},{"key":"BF03346550_CR35","first-page":"66","volume":"43","author":"S Szak\u00e1ll Jr","year":"2002","unstructured":"Szak\u00e1ll S Jr, Esik O, Bajzik G, et al. 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma. J Nucl Med 2002, 43: 66\u201371.","journal-title":"J Nucl Med"},{"key":"BF03346550_CR36","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1210\/jc.2007-1211","volume":"92","author":"AL Giraudet","year":"2007","unstructured":"Giraudet AL, Vanel D, Leboulleux S, et al. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 2007, 92: 4185\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346550_CR37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cpet.2008.04.004","volume":"2","author":"M Urhan","year":"2007","unstructured":"Urhan M, Mavi A, Alavi A, Nanni C. Positron emission tomography and thyroid cancer. PET Clinics 2007, 2: 295\u2013304.","journal-title":"PET Clinics"},{"key":"BF03346550_CR38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cpet.2008.04.005","volume":"2","author":"G Grassetto","year":"2007","unstructured":"Grassetto G, Alavi A, Rubello D. PET and parathyroid. PET Clinics 2007, 2: 385\u201393.","journal-title":"PET Clinics"},{"key":"BF03346550_CR39","first-page":"1809","volume":"37","author":"DR Neumann","year":"1996","unstructured":"Neumann DR, Esselstyn CB, Maclntyre WJ, Go RT, Obuchowski NA, Chen EQ, Licata AA. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med 1996, 37: 1809\u201315.","journal-title":"J Nucl Med"},{"key":"BF03346550_CR40","first-page":"2000","volume":"37","author":"DR Neumann","year":"1996","unstructured":"Neumann DR, Esselstyn CB, Kim EY. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings. J Nucl Med 1996, 37: 2000\u20131.","journal-title":"J Nucl Med"},{"key":"BF03346550_CR41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/eje.0.1390195","volume":"139","author":"GJR Cook","year":"1998","unstructured":"Cook GJR, Wong JCH, Smellie WJB, Young AE, Maisey MN, Fogelman I. 11C Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. Eur J Endocrinol 1998, 139: 195\u20137.","journal-title":"Eur J Endocrinol"},{"key":"BF03346550_CR42","first-page":"1766","volume":"37","author":"A Sundin","year":"1996","unstructured":"Sundin A, Johansson C, Hellman P, et al. PET and parathyroid L-[carbon-11] methionine accumulation in hyperparathyroidism. J Nucl Med 1996, 37: 1766\u201370.","journal-title":"J Nucl Med"},{"key":"BF03346550_CR43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00006231-200502000-00009","volume":"26","author":"A Beggs","year":"2005","unstructured":"Beggs A, Hain S. Localization of parathyroid adenomas using 11Cmethionine positron emission tomography. Nucl Med Commun 2005, 26: 133\u20136.","journal-title":"Nucl Med Commun"},{"key":"BF03346550_CR44","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00259-004-1610-1","volume":"31","author":"D Otto","year":"2004","unstructured":"Otto D, Boerner A, Hofmann M, et al. Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET. Eur J Nucl Med Mol Imaging 2004, 31: 1405\u201312.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BF03346550_CR45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.beem.2004.11.001","volume":"19","author":"B Eriksson","year":"2005","unstructured":"Eriksson B, Orlefors H, Oberg K, Sundin A, Bergstr\u00f6m M, L\u00e5ngstr\u00f6m B. Developments in PET for the detection of endocrine tumours. Best Pract Res Clin Endocrinol Metab 2005, 19: 311\u201324.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"BF03346550_CR46","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/er.2003-0014","volume":"25","author":"GA Kaltsas","year":"2004","unstructured":"Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 2004, 25: 458\u2013511.","journal-title":"Endocr Rev"},{"key":"BF03346550_CR47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bpg.2005.02.010","volume":"19","author":"G Kloppel","year":"2005","unstructured":"Kloppel G, Anlauf M. Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2005, 19: 507\u201317.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"BF03346550_CR48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.beem.2004.09.001","volume":"19","author":"I Virgolini","year":"2005","unstructured":"Virgolini I, Traub-Weidinger T, Decristoforo C. Nuclear medicine in the detection and management of pancreatic islet-cell tumours. Best Pract Res Clin Endocrinol Metab 2005, 19: 213\u201327.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"BF03346550_CR49","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","volume":"20","author":"EP Krenning","year":"1993","unstructured":"Krenning EP, Kwekkeboom DJ, BakkerWH, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993, 20: 716\u201331.","journal-title":"Eur J Nucl Med"},{"key":"BF03346550_CR50","first-page":"459","volume":"41","author":"O Schillaci","year":"2000","unstructured":"Schillaci O, Massa R, Scopinaro F. 111ln-pentetreotide scintigraphy in the detection of insulinomas: importance of SPECT imaging. J Nucl Med 2000, 41: 459\u201362.","journal-title":"J Nucl Med"},{"key":"BF03346550_CR51","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/1078-0432.CCR-03-0359","volume":"10","author":"M Schottelius","year":"2004","unstructured":"Schottelius M, Poethko T, Herz M, et al. First 18F-Iabeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Clinical Cancer Research 2004, 10: 3593\u2013606.","journal-title":"Clinical Cancer Research"},{"key":"BF03346550_CR52","first-page":"4087","volume":"27","author":"A Al-Nahhas","year":"2007","unstructured":"Al-Nahhas A, Win Z, Szyszko T, Singh A, Nanni C, Fanti S, Rubello D. Gallium-68 PET: a new frontier in receptor cancer imaging. Anticancer Res 2007, 27: 4087\u201394.","journal-title":"Anticancer Res"},{"key":"BF03346550_CR53","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.mnm.0000224462.44051.d2","volume":"27","author":"C Nanni","year":"2006","unstructured":"Nanni C, Rubello D, Al-Nahhas A, Fanti S. Clinical PET in oncology: not only FDG. Nucl Med Commun 2006, 27: 685\u20138.","journal-title":"Nucl Med Commun"},{"key":"BF03346550_CR54","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","volume":"28","author":"M Hofmann","year":"2001","unstructured":"Hofmann M, Maecke H, Borner R, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminery data. Eur J Nucl Med 2001, 28: 1751\u20137.","journal-title":"Eur J Nucl Med"},{"key":"BF03346550_CR55","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","volume":"48","author":"M Gabriel","year":"2007","unstructured":"Gabriel M, Decristoforo C, Kendler D, et al. 68Ga-DOTA-Try3-octeriotide PET in neuroendocrine tumours: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 2007, 48: 508\u201318.","journal-title":"J Nucl Med"},{"key":"BF03346550_CR56","first-page":"66","volume":"51","author":"R Junik","year":"2006","unstructured":"Junik R, Drobik P, Ma\u0142kowski B, Kobus-B\u0142achnio K. The role of positron emission tomography (PET) in diagnostics of gastroenteropancreatic neuroendocrine tumours (GEP NET). Adv Med Sci 2006, 51: 66\u20138.","journal-title":"Adv Med Sci"},{"key":"BF03346550_CR57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiology.220.2.r01au25373","volume":"220","author":"S Hoegerle","year":"2001","unstructured":"Hoegerle S, Altehoefer C, Ghanem N, et al. Whole-body 18-FDOPA PET for detection of gastrointestinal carcinoid tumors. Radiology 2001, 220: 373\u201380.","journal-title":"Radiology"},{"key":"BF03346550_CR58","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00259-008-0769-2","volume":"35","author":"V Ambrosini","year":"2008","unstructured":"Ambrosini V, Tomassetti P, Castellucci P, et al. Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2008, 35: 1431\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BF03346550_CR59","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.195.2.7724749","volume":"195","author":"H Ahlstrom","year":"1995","unstructured":"Ahlstrom H, Eriksson B, Bergstr\u00f6m M, Bjurling P, L\u00e5ngstr\u00f6m B, Oberg K. Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 1995, 195: 333\u20137.","journal-title":"Radiology"},{"key":"BF03346550_CR60","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.1998.16.7.2534","volume":"16","author":"H Orlefors","year":"1998","unstructured":"Orlefors H, Sundin A, Ahlstr\u00f6m H, et al. Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors. J Clin Oncol 1998, 16: 2534\u201341.","journal-title":"J Clin Oncol"},{"key":"BF03346550_CR61","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1210\/jc.2004-1938","volume":"90","author":"H Orlefors","year":"2005","unstructured":"Orlefors H, Sundin A, Garske U, et al. Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 2005, 90: 3392\u2013400.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346550_CR62","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2007.15.1126","volume":"26","author":"KP Koopmans","year":"2008","unstructured":"Koopmans KP. Neels OC. Kema IP, et al. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenylalanine and 11C-5-hydroxy-tryptophan positron emission tomography. J Clin Oncol 2008, 26: 1489\u201395.","journal-title":"J Clin Oncol"},{"key":"BF03346550_CR63","first-page":"213","volume":"42","author":"CJ Anderson","year":"2001","unstructured":"Anderson CJ, Dehdashti F, Cutler PD, et al. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumours. J Nucl Med 2001, 42: 213\u201321.","journal-title":"J Nucl Med"},{"key":"BF03346550_CR64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000095529","volume":"83","author":"C Muhr","year":"2006","unstructured":"Muhr C. Positron emission tomography in acromegaly and other pituitary adenoma patients. Neuroendocrinology 2006, 83: 205\u201310.","journal-title":"Neuroendocrinology"},{"issue":"Suppl1","key":"BF03346550_CR65","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1530\/eje.1.02349","volume":"156","author":"WW Herder de","year":"2007","unstructured":"de Herder WW, Reijs AE, Feelders RA, et al. Diagnostic imaging of dopamine receptors in pituitary adenomas. Eur J of Endocrinol 2007, 156(Suppl 1): S53\u20136.","journal-title":"Eur J of Endocrinol"},{"key":"BF03346550_CR66","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.rlu.0000191779.75532.05","volume":"31","author":"CW Koo","year":"2006","unstructured":"Koo CW, Bhargava P, Rajagopalan V, Ghesani M, Sims-Childs H, Kagetsu NJ. Incidental detection of clinically occult pituitary adenoma on whole-body FDG PET imaging. Clin Nucl Med 2006, 31: 42\u20133.","journal-title":"Clin Nucl Med"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346550\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T01:16:32Z","timestamp":1565313392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,9]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BF03346550"],"URL":"https:\/\/doi.org\/10.1007\/bf03346550","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,9]]}}}